Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Alejandro Garcia-Horton"'
Autor:
Stephanie A. Maier, Imran Ahmad, Tobias Berg, Susan Berrigan, Mahmoud Elsawy, Alejandro Garcia-Horton, Wilson Lam, Alix Lapworth, Luciana Melo Garcia, Ravi M. Shah, Ram Vasudevan Nampoothiri, Jean-Sébastien Delisle
Publikováno v:
Current Oncology, Vol 31, Iss 6, Pp 2918-2951 (2024)
On behalf of Cell Therapy Transplant Canada (CTTC), we are pleased to present the Abstracts of the CTTC 2023 Annual Conference. The conference was held in-person, 31 May–2 June 2023, in Halifax, Nova Scotia at the Westin Nova Scotian hotel. Poster
Externí odkaz:
https://doaj.org/article/280775e1430347e8b7e188c2804e3b2c
Autor:
Stephanie A. Maier, Tobias Berg, Susan Berrigan, Jonathan Bramson, Chris Bredeson, Guy Cantin, Andrew Daly, Gwynivere A. Davies, Mahmoud Elsawy, Alejandro Garcia-Horton, Wilson Lam, Alix Lapworth, Kylie Lepic, Luciana Melo Garcia, Kirk R. Schultz, Ram Vasudevan Nampoothiri, Darrell White, Jean-Sébastien Delisle
Publikováno v:
Current Oncology, Vol 29, Iss 12, Pp 9970-10017 (2022)
On behalf of Cell Therapy Transplant Canada (CTTC), we are pleased to present the Abstracts of the CTTC 2022 Annual Conference. The conference was held in-person 15–18 June 2022, in Niagara Falls, Ontario. Poster authors presented their work during
Externí odkaz:
https://doaj.org/article/68ea8c1d5ffe42aa9ed762e1b2e8642a
Autor:
Alejandro Garcia‐Horton, Sunu L. Cyriac, Tobias Gedde‐Dahl, Yngvar Floisand, Mats Remberger, Jonas Mattsson, Fotios V. Michelis
Publikováno v:
European journal of haematologyREFERENCES. 109(6)
Mixed results surround the accuracy of commonly used prognostic risk scores to predict overall survival (OS) and non-relapse mortality (NRM) in allogeneic hematopoietic stem cell transplant (allo-HCT) recipients. We hypothesize that a simple prognost
Autor:
Brittany Salter, Omar Raslan, Suzanne Demczuk, Brian Leber, Alejandro Garcia-Horton, Irwin Walker, Tobias Berg, Darci Butcher, Kylie L. Lepic, Elizabeth McCready, Parveen Wasi, Dina Khalaf
Publikováno v:
Blood. 140:12916-12917
Autor:
Omar Raslan, Alejandro Garcia-Horton
Publikováno v:
Expert opinion on pharmacotherapy. 23(8)
Acute myeloid leukemia (AML) predominantly affects elderly population. This poses challenges in management, as patients are frequently not candidates for intensive therapy given comorbidities or frailty. Currently, azacitidine (AZA), either as monoth
Publikováno v:
Journal of the National Comprehensive Cancer Network. 18:1421-1428
With the success of tyrosine kinase inhibitors (TKIs) in achieving next-to-normal overall survival in chronic myeloid leukemia (CML), treatment-free remission (TFR) has become a significant goal in the management of this disease. Discontinuation of t
Autor:
Alejandro Garcia-Horton, Karen Wl Yee
Publikováno v:
Expert Opinion on Pharmacotherapy. 21:2077-2090
Up to 30% of patients with acute myeloid leukemia (AML) have a mutation in the FLT3 receptor. Molecular targets have acquired a significant interest in the treatment of AML and are changing patient outcomes, including improvement of overall survival
Autor:
Caroline J McNamara, Tracy Murphy, Dawn Maze, Hassan Sibai, Alejandro Garcia-Horton, Vikas Gupta
Publikováno v:
Leukemia & Lymphoma. 62:1525-1527
Patients with Philadelphia negative myeloproliferative neoplasms (MPNs), including polycythemia vera (PV), essential thrombocytosis (ET), and myelofibrosis (MF), are at risk of progressing into acu...
Autor:
Alejandro Lazo-Langner, Jorge Valenzuela-Tamariz, Patricia Ramos-Salazar, Alejandra Zarate-Osorno, Lourdes Molinar-Horcasitas, Alejandro Garcia-Horton, Rogelio Sanchez-Verin-Lucio, Lizbeth Palma-Berre, Adrian Carballo-Zarate
Publikováno v:
Journal of Hematopathology. 11:99-105
Epidemiology of lymphoma is not well described in Mexico. We determined the frequencies and subtypes of the main non-Hodgkin’s and Hodgkin’s lymphomas in the Mexican population. Files for tissue samples for lymphomas stored in five different hosp
Autor:
Elliot Charles Smith, Caroline J McNamara, Hassan Sibai, Dawn Maze, Vikas Gupta, Alejandro Garcia-Horton
Publikováno v:
Leukemialymphoma. 62(2)
Hepatitis B virus (HBV) reactivation in patients with hematologic malignancies treated with immunosuppressive therapy is a well-known risk. Over 257 million people worldwide are chronic carriers of...